Association Between Cannabinoid Receptor-1 Gene Polymorphism and the Risk of Diabetic Nephropathy Among Patients with Type 2 Diabetes Mellitus

Pharmacogenomics and Personalized Medicine
Xuelian ZhangChunyu Zhang

Abstract

The cannabinoid receptor 1 (CNR1) gene polymorphism is reportedly associated with components of metabolic syndrome and coronary artery diseases in patients with type 2 diabetes mellitus (T2DM). We investigated whether the common variant rs10493353 polymorphism is associated with diabetic nephropathy (DN) in T2DM patients. T2DM patients with DN were enrolled as a case group, and patients with only T2DM as a control group. Demographic data and biochemical parameters were collected. The polymerase chain reaction-based restriction fragment length polymorphism technique was used for genotyping. The odds ratio and 90% confidence interval were calculated to assess the association between genotypes and the risk of DN. In total, 320 T2DM patients and 320 DN patients were enrolled. Compared with T2DM patients, the DN patients have a significantly larger body mass index (BMI), longer duration of disease, and higher proportions of smokers, drinkers, and hypertension. The risk of DN was significantly decreased by genotypes AA (OR=0.39, 95% CI=0.23-0.67) and GA (OR=0.53, 95% CI=0.37-0.75) vs GG (codominant model), GA/AA vs GG (OR=0.49, 95% CI=0.35-0.67; dominant model), AA vs GG/GA (OR=0.47, 95% CI=0.28-0.80; recessive model), and the A alle...Continue Reading

References

Feb 1, 1996·The Journal of Clinical Endocrinology and Metabolism·D CozzolinoR Torella
Jul 16, 2003·Annals of Internal Medicine·Andrew S LeveyUNKNOWN National Kidney Foundation
Dec 24, 2004·Diabetes Care·Jorge L GrossThemis Zelmanovitz
Sep 14, 2006·Pharmacological Reviews·Pál PacherGeorge Kunos
Feb 25, 2011·Diabetes·Wook KimJosephine M Egan
Oct 18, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Bjørn Odvar EriksenIngrid Toft
Dec 6, 2011·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Rui WangLu Qiang
Jun 17, 2014·Nutrition Research Reviews·Gerry Jager, Renger F Witkamp
Jan 30, 2016·Endocrine Development·Alena Stančáková, Markku Laakso
Nov 2, 2016·Circulation·Biykem BozkurtUNKNOWN American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Car
Sep 29, 2017·Cardiovascular Drugs and Therapy·Corey MageeDerek P Brazil
Feb 17, 2018·Circulation·Zengwu WangUNKNOWN China Hypertension Survey Investigators
Aug 4, 2018·The Lancet. Planetary Health·Benjamin BoweZiyad Al-Aly
Aug 18, 2018·Nature Reviews. Drug Discovery·Vincenzo Di Marzo
Sep 6, 2018·Journal of Community Hospital Internal Medicine Perspectives·Krishna C KeriSamuel Blumenthal
May 24, 2019·European Journal of Endocrinology·Katrien BenhalimaChantal Mathieu
May 30, 2019·World Journal of Diabetes·Jonathan KopelKenneth Nugent
Dec 22, 2019·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
electrophoresis
genotyping

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.